Firefly Neuroscience

Firefly Neuroscience is an FDA-cleared neurodiagnostic software platform company specializing in objective brain health assessment and early detection of neurological and psychiatric conditions. The company's flagship product, Evoke™ System, combines quantitative EEG (qEEG) and event-related potentials (ERP) analysis with proprietary AI and machine learning to translate complex brain signals into clinically actionable insights. Built on a proprietary database of over 191,000 EEG and ERP sessions from individuals aged 12–85, Evoke™ enables clinicians to identify deviations in brain function, differentiate overlapping conditions (depression, anxiety, ADHD, concussion, cognitive decline, neurodegenerative disorders), and track treatment response with precision. The platform delivers age-matched normative comparisons and cloud-based reporting to support earlier diagnosis, more targeted treatment planning, and personalized care protocols. Firefly serves healthcare practitioners seeking measurable, data-driven neurological assessment and supports CNS drug developers through biomarker development and companion diagnostic collaborations.